Board of Directors authorized a new $200 million share repurchase program.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HRMY:
- Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
- Harmony Biosciences Holdings, Inc. (HRMY) Q3 Earnings Cheat Sheet
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- Harmony Biosciences price target lowered to $28 from $54 at Mizuho
- Harmony Biosciences price target lowered to $53 from $66 at Needham